2
Orphan Designations
0 approved, 2 designated
0
FDA Approvals
5
Active Trials
200 recruiting
2
Rare Diseases
across 8 areas
0
News (30d)
Quiet
Innovent Biologics (Suzhou) Co. Ltd is a company with 2 orphan drug designations across 2 rare diseases. Active clinical trials in 5 indications.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| T-cell non-Hodgkin lymphoma | sintilimab | Des.TrialAppr. |
| brain neoplasm | - | Des.TrialAppr. |
| cancer | - | Des.TrialAppr. |
| esophageal cancer | Sintilimab | Des.TrialAppr. |
| lymphoma | - | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
38
overlap in 2+ diseases
0/5
candidate diseases
0
avg importance: 0
0
affecting portfolio
0% of portfolio targets high unmet need diseases
38
overlap in 2+ diseases
0/5
candidate diseases
0
avg importance: 0
0
affecting portfolio